✦ LIBER ✦

Therapeutic potential of hydroxychloroquine on serum B-cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients

✍ Scribed by Mahdy, Amina A.; Raafat, Hala A.; El-Fishawy, Hussein S.; Gheita, Tamer A.

Book ID: 122306730
Publisher: Egypts Presidential Specialized Council for Education and Scientific Research
Year: 2014
Tongue: English
Weight: 664 KB
Volume: 52
Category: Article
ISSN: 1110-0931
DOI: 10.1016/j.bfopcu.2014.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of interleukin-2 on synthesis of

Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells

✍ Katsuya Suzuki; Yumiko Setoyama; Keiko Yoshimoto; Kensei Tsuzaka; Tohru Abe; Tsu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 213 KB

The Expression of B-Cell Activating Fact

The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection

✍ H. Xu; X. He; J. Sun; D. Shi; Y. Zhu; X. Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Polymorphism and chromosomal mapping of

Polymorphism and chromosomal mapping of the mouse gene for B-cell activating factor belonging to the tumor necrosis factor family (Baff) and association with the autoimmune phenotype

✍ Yi Jiang, Mareki Ohtsuji, Masaaki Abe, Na Li, Yan Xiu, Xiang Wen, Toshikazu Shir 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 50 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Alterations in peripheral blood memory B

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

✍ M Margarida Souto-Carneiro, Vijayabhanu Mahadevan… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 449 KB

The Effect of tumor necrosis factor bloc

The Effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis

✍ Ori Elkayam; Dan Caspi; Tatiana Reitblatt; Darlene Charboneau; Jeffrey B. Rubins 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB